Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Paul R. Krakovitz, MD, is the Section Head of Pediatric Otolaryngology at Cleveland Clinic, Assistant Professor at Case Western Reserve College of Medicine. He also serves as the Vice Chairman of Surgical Operations for the Cleveland Clinic. He is an avid researcher and innovator. He has leadership roles in both the American Academy of Otolaryngology - Head and Neck Surgery as well as the American Society of Pediatric Otolaryngology.
His specialty interests include the management of pediatric thyroid cancer, childhood head and neck masses, and surgical management of complex airway disease. He has published over 30 peer-reviewed articles and book chapters and is a frequent invited lecturer nationally as well as internationally.
Dr. Krakovitz completed his medical school training at Indiana University School of Medicine in 1997, and went on to finish his Otolaryngology-Head and Neck Surgery residency training at The University of Vermont in 2002. Dr. Krakovitz served as Chief Resident at Dartmouth Hitchcock 2000-2001. Following his residency, he completed advanced studies in Pediatric Otolaryngology as Fellow at Cleveland Clinic Children's Hospital. Dr. Krakovitz has practiced Pediatric Otolaryngology since 2003 at Cleveland Clinic.
Pediatric endocrine surgery - thyroid and parathyroid disease; benign, malignant, and congenital head and neck surgery; hemangiomas and vascular malformations, complex endoscopic and open airway surgery
Awards & Honors
Innovator Award Otolaryngology & Communicative Disorders in 2010 and 2012
Ultrasound of the head and neck
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 1/28/2016, Dr. Krakovitz has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.